Analysing Recent Socioeconomic Trends in Coronary Heart Disease Mortality in England, 2000–2007: A Population Modelling Study
Background:
Coronary heart disease (CHD) mortality in England fell by approximately 6% every year between 2000 and 2007. However, rates fell differentially between social groups with inequalities actually widening. We sought to describe the extent to which this reduction in CHD mortality was attributable to changes in either levels of risk factors or treatment uptake, both across and within socioeconomic groups.
Methods and Findings:
A widely used and replicated epidemiological model was used to synthesise estimates stratified by age, gender, and area deprivation quintiles for the English population aged 25 and older between 2000 and 2007. Mortality rates fell, with approximately 38,000 fewer CHD deaths in 2007. The model explained about 86% (95% uncertainty interval: 65%–107%) of this mortality fall. Decreases in major cardiovascular risk factors contributed approximately 34% (21%–47%) to the overall decline in CHD mortality: ranging from about 44% (31%–61%) in the most deprived to 29% (16%–42%) in the most affluent quintile. The biggest contribution came from a substantial fall in systolic blood pressure in the population not on hypertension medication (29%; 18%–40%); more so in deprived (37%) than in affluent (25%) areas. Other risk factor contributions were relatively modest across all social groups: total cholesterol (6%), smoking (3%), and physical activity (2%). Furthermore, these benefits were partly negated by mortality increases attributable to rises in body mass index and diabetes (−9%; −17% to −3%), particularly in more deprived quintiles. Treatments accounted for approximately 52% (40%–70%) of the mortality decline, equitably distributed across all social groups. Lipid reduction (14%), chronic angina treatment (13%), and secondary prevention (11%) made the largest medical contributions.
Conclusions:
The model suggests that approximately half the recent CHD mortality fall in England was attributable to improved treatment uptake. This benefit occurred evenly across all social groups. However, opposing trends in major risk factors meant that their net contribution amounted to just over a third of the CHD deaths averted; these also varied substantially by socioeconomic group. Powerful and equitable evidence-based population-wide policy interventions exist; these should now be urgently implemented to effectively tackle persistent inequalities.
: Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Analysing Recent Socioeconomic Trends in Coronary Heart Disease Mortality in England, 2000–2007: A Population Modelling Study. PLoS Med 9(6): e32767. doi:10.1371/journal.pmed.1001237
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001237
Souhrn
Background:
Coronary heart disease (CHD) mortality in England fell by approximately 6% every year between 2000 and 2007. However, rates fell differentially between social groups with inequalities actually widening. We sought to describe the extent to which this reduction in CHD mortality was attributable to changes in either levels of risk factors or treatment uptake, both across and within socioeconomic groups.
Methods and Findings:
A widely used and replicated epidemiological model was used to synthesise estimates stratified by age, gender, and area deprivation quintiles for the English population aged 25 and older between 2000 and 2007. Mortality rates fell, with approximately 38,000 fewer CHD deaths in 2007. The model explained about 86% (95% uncertainty interval: 65%–107%) of this mortality fall. Decreases in major cardiovascular risk factors contributed approximately 34% (21%–47%) to the overall decline in CHD mortality: ranging from about 44% (31%–61%) in the most deprived to 29% (16%–42%) in the most affluent quintile. The biggest contribution came from a substantial fall in systolic blood pressure in the population not on hypertension medication (29%; 18%–40%); more so in deprived (37%) than in affluent (25%) areas. Other risk factor contributions were relatively modest across all social groups: total cholesterol (6%), smoking (3%), and physical activity (2%). Furthermore, these benefits were partly negated by mortality increases attributable to rises in body mass index and diabetes (−9%; −17% to −3%), particularly in more deprived quintiles. Treatments accounted for approximately 52% (40%–70%) of the mortality decline, equitably distributed across all social groups. Lipid reduction (14%), chronic angina treatment (13%), and secondary prevention (11%) made the largest medical contributions.
Conclusions:
The model suggests that approximately half the recent CHD mortality fall in England was attributable to improved treatment uptake. This benefit occurred evenly across all social groups. However, opposing trends in major risk factors meant that their net contribution amounted to just over a third of the CHD deaths averted; these also varied substantially by socioeconomic group. Powerful and equitable evidence-based population-wide policy interventions exist; these should now be urgently implemented to effectively tackle persistent inequalities.
: Please see later in the article for the Editors' Summary
Zdroje
1. BajekalMScholesSO'FlahertyMRaineRNormanP 2010 Trends in CHD mortality by socioeconomic circumstances, England 1982–2006. J Epidemiol Community Health 64Suppl 1 p.A2
2. The Marmot Review 2010 Fair society, healthy lives: strategic review of health inequalities in England post-2010. London: The Marmot Review, Available: http://www.instituteofhealthequity.org/projects/fair-society-healthy-lives-the-marmot-review
3. LeylandAH 2004 Increasing inequalities in premature mortality in Great Britain. J Epidemiol Community Health 58 296 302
4. UnalBCritchleyJACapewellS 2004 Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 109 1101 1107
5. FordESAjaniUACroftJBCritchleyJALabartheDR 2007 Explaining the decrease in US deaths from coronary disease, 1980–2000. N Engl J Med 356 2388 2398 Detailed technical appendix of model available available: http://www.nejm.org/doi/suppl/10.1056/NEJMsa053935/suppl_file/nejm_ford_2388sa1.pdf
6. WijeysunderaHCMachadoMFarahatiFWangXWittemanW 2010 Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994–2005. JAMA 303 1841 1847
7. Department of Health 2000 National service framework for coronary heart disease Crown Copyright, London Department of Health
8. The NHS Information Centre for Health and Social Care 2004 Quality and outcomes framework: Introduction to QOF. Available: http://www.ic.nhs.uk/statistics-and-data-collections/supporting-information/audits-and-performance/the-quality-and-outcomes-framework/qof-information/introduction-to-qof. Accessed 8 May 2012
9. UK Food Standards Agency 2006 New salt reduction targets published as part of FSA campaign to reduce salt in our diets. Available: http://webarchive.nationalarchives.gov.uk/20120206100416/http://food.gov.uk/news/pressreleases/2006/mar/targets. Accessed 8 May 2012
10. UK Food Standards Agency 2007 FSA Board recommends voluntary approach to trans fats in food. Available: http://webarchive.nationalarchives.gov.uk/20120206100416/http://food.gov.uk/news/newsarchive/2007/dec/trans. Accessed 8 May 2012
11. House of Commons Committee of Public Accounts 2010 Tackling inequalities in life expectancy in areas with the worst health and deprivation. House of Commons London: The Stationery Office Limited. Available: http://www.publications.parliament.uk/pa/cm201011/cmselect/cmpubacc/470/470.pdf. Accessed 8 May 2012
12. CapewellSGrahamH 2010 Will cardiovascular disease prevention widen health inequalities? PLoS Med 7 e10000320 doi:10.1371/journal.pmed.1000320
13. Department for Communities and Local Government 2007 The English indices of deprivation 2007. Available www.communities.gov.uk/publications/communities/indicesdeprivation07. Accessed 8 May 2012
14. MantJHicksN 1995 Detecting differences in quality of care - the sensitivity of measures of process and outcome in treating acute myocardial infarction. BMJ 311 793 796
15. KuulasmaaKTunstall-PedoeHDobsonAFortmannSSansS 2000 Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA project populations. Lancet 355 675 687
16. BarendregtJJ 2010 The effect size in uncertainty analysis. Value in Health 13 388 391
17. Tunstall-PedoeHConnaghanJWoodwardMTolonenHKuulasmaaK 2006 Pattern of declining blood pressure across replicate population surveys of the WHO MONICA project, mid-1980s to mid-1990s, and the role of medication. BMJ 332 629 632
18. UK Food Standards Agency 2008 An assessment of dietary sodium levels among adults (aged 19–64) in the UK general population in 2008, based on analysis of dietary sodium in 24 hour urine samples. London: National Centre for Social Research. Available: http://www.food.gov.uk/multimedia/pdfs/08sodiumreport.pdf. Accessed 8 May 2012
19. DanaeiGFinucaneMMLinJKSinghGMPaciorekCJ 2011 National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants. Lancet 377 568 577
20. BauldLJudgeKPlattS 2007 Assessing the impact of smoking cessation services on reducing health inequalities in England: observational study. Tob Control 16 400 404
21. National Institute of Health and Clinical Excellence 2010 Prevention of cardiovascular disease at population level. Available: http://guidance.nice.org.uk/PH25/. Accessed 8 May 2012
22. Foresight 2007 Tackling obesities: future choices. UK Government Office of Science. Available: http://www.bis.gov.uk/foresight/our-work/projects/published-projects/tackling-obesities/reports-and-publications
23. YusufSHawkenSOunpuuSDansTAvezumA 2004 Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 937 952
24. KivimäkiMShipleyMJFerrieJESingh-ManouxABattyGD 2008 Best-practice interventions to reduce socioeconomic inequalities of coronary heart disease mortality in UK: a prospective occupational cohort study. Lancet 372 1648 1654
25. KivimäkiMLawlorDADavey SmithGKouvonenAVirtanenM 2007 Socioeconomic position, co-occurrence of behavior-related risk factors, and coronary heart disease: the Finnish Public Sector study. Am J Public Health 97 874 879
26. HaraldKKoskinenSJousilahtiPTorppaJVartiainenE 2008 Changes in traditional risk factors no longer explain time trends in cardiovascular mortality and its socioeconomic differences. J Epidemiol Community Health 62 251 257
27. National Co-ordinating Centre for NHS Service Delivery and Organisation R&D 2005 Concordance, adherence and compliance in medicine taking. Available: http://www.medslearning.leeds.ac.uk/pages/documents/useful_docs/76-final-report%5B1%5D.pdf. Accessed 8 May 2012
28. OckeneJMaYZapkaJPbertLValentine GoinsK 2002 Spontaneous cessation of smoking and alcohol use among low-income pregnant women. Am J Prev Med 23 150 159
29. SchüzBMarxCWurmSWarnerLMZiegelmannJP 2011 Medication beliefs predict medication adherence in older adults with multiple illnesses J Psychosom Res 70 179 187
30. CapewellSMorrisonCEMcMurrayJJ 1999 Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart 81 380 386
31. CapewellSBeagleholeRSeddonMMcMurrayJ 2000 Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993. Circulation 102 1511 1516
32. PalmieriLBennettKGiampaoliSCapewellS 2010 Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000. Am J Public Health 100 684 692
33. AspelundTGudnasonVMagnusdottirBTAndersenKSigurdssonG 2010 Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25–74 between the years 1981 and 2006. PloS One 5 e13957 doi:10.1371/journal.pone.0013957
34. LeylandAH 2005 Socioeconomic gradients in the prevalence of cardiovascular disease in Scotland: the roles of composition and context. J Epidemiol Community Health 59 799 803
35. LaatikainenTCritchleyJVartiainenESalomaaVKetonenM 2005 Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol 162 764 773
36. Davey SmithGHartCWattGHoleDHawthorneV 1998 Individual social class, area-based deprivation,cardiovascular disease risk factors, and mortality: the Renfrew and Paisley study. J Epidemiol Community Health 52 399 405
37. DoranTKontopantelisEValderasJMCampbellSRolandM 2011 Effect of financial incentives on incentivised and non-incentivised clinical activities: longitudinal analysis of data from the UK Quality and Outcomes Framework. BMJ 342 d3590 doi:10.1136/bmj.d3590
38. ZatonskiWAWillettW 2005 Changes in dietary fat and declining coronary heart disease in Poland: population based study. BMJ 331 187 188
39. CobiacLJVosTVeermanJL 2010 Cost-effectiveness of interventions to reduce dietary salt intake. Heart 96 1920 1925
40. GlantzSGonzalezM 2012 Effective tobacco control is key to rapid progress in reduction of non-communicable diseases. Lancet 379 1269 1271
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2012 Číslo 6
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
Najčítanejšie v tomto čísle
- Why Human Health and Health Ethics Must Be Central to Climate Change Deliberations
- Clinical Trials Have Gone Global: Is This a Good Thing?
- Point-of-Care Tests to Strengthen Health Systems and Save Newborn Lives: The Case of Syphilis
- Tobacco Industry Manipulation of Tobacco Excise and Tobacco Advertising Policies in the Czech Republic: An Analysis of Tobacco Industry Documents